Skip to content
Home/Companies/Healthcare/AML-Riatol

AML-Riatol

Healthcare·Belgium·Exited 2010·Held 3yr
Entry
2007
Hold
3yr
Exit
2010

Who owns AML-Riatol?

AML-Riatol was owned by Waterland Private Equity through Waterland Private Equity Fund III (WPEF III) (2005 vintage) from 2007 to 2010, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

Waterland Private Equity
Investor
Waterland Private Equity
Waterland Private Equity Fund III (WPEF III) · 2005 · Buyout

Key facts

HQBelgium
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2010

More from Waterland Private Equity Fund III (WPEF III)

Other portfolio companies in the same fund.

Indicator
Exited 2011
Business ServicesBelgium· 2007
Interbest
Exited 2019
AdTechNetherlands· 2007
to
V!go
Exited 2011
MedTechBelgium· 2007
to
Global Collect
Exited 2007
FintechNetherlands· 2006
to
Lowen Play
Lowen Play
Exited 2008
GamingGermany· 2006
to
Excent Tandtechniek
Exited 2008
MedTechNetherlands· 2005
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track AML-Riatol

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on AML-Riatol.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue